or Try an Advanced Search...

    Technical Analysis for PEPG - PepGen Inc.

    Grade Last Price % Change Price Change
    C 13.70 -1.86% -0.26
    PEPG closed down 1.86 percent on Wednesday, May 8, 2024, on 28 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical PEPG trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    NR7 Range Contraction -1.86%
    Upper Bollinger Band Walk Strength -1.86%
    Inside Day Range Contraction -1.86%
    Wide Bands Range Expansion -1.86%
    Overbought Stochastic Strength -1.86%
    Stochastic Sell Signal Bearish -1.79%
    Older End-of-Day Signals for PEPG ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 13 hours ago
    Possible Inside Day about 13 hours ago
    Down 1% about 15 hours ago
    60 Minute Opening Range Breakdown about 16 hours ago
    Up 1% about 17 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    PEPG Chart by TradingView
    Basic chart:

    Profile

    PepGen, Inc. is a clinical-stage biotechnology company advancing the next-generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases. PepGen’s Enhanced Deliver Oligonucleotide, or EDO, platform is founded on over a decade of research and development and leverages cell-penetrating peptides to improve the uptake and activity of conjugated oligonucleotide therapeutics. Using these EDO peptides, we are generating a pipeline of oligonucleotide therapeutic candidates that target the root cause of serious diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Molecular Biology Cell Biology Peptides Oligonucleotide Nucleic Acids

    Is PEPG a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 25 Best Momentum Stocks to Buy for April 25th
    Mar 13 PepGen to Participate in Upcoming Investor Conferences
    Mar 13 PepGen Receives U.S. FDA Orphan Drug and Rare Pediatric Disease Designations for PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
    Mar 12 Can PepGen, Inc. (PEPG) Climb 48.62% to Reach the Level Wall Street Analysts Expect?
    Mar 11 PepGen, Inc. (PEPG) Upgraded to Buy: What Does It Mean for the Stock?
    Mar 7 PepGen, Inc. (PEPG) Q4 2023 Earnings Call Transcript
    Mar 6 PepGen reports Q4 results
    Mar 6 PepGen Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Developments
    Mar 4 PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
    Feb 20 PepGen Receives U.S. FDA Fast Track Designation for PGN-EDODM1 for the Treatment of Myotonic Dystrophy Type 1
    See more PEPG news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 17.51
    52 Week Low 3.725
    Average Volume 87,330
    200-Day Moving Average 8.48
    50-Day Moving Average 13.48
    20-Day Moving Average 12.56
    10-Day Moving Average 13.18
    Average True Range 1.12
    RSI (14) 55.56
    ADX 17.1
    +DI 24.09
    -DI 14.47
    Chandelier Exit (Long, 3 ATRs) 11.86
    Chandelier Exit (Short, 3 ATRs) 13.57
    Upper Bollinger Bands 14.75
    Lower Bollinger Band 10.36
    Percent B (%b) 0.76
    BandWidth 34.94
    MACD Line 0.29
    MACD Signal Line 0.00
    MACD Histogram 0.2859
    Fundamentals Value
    Market Cap 326.24 Million
    Num Shares 23.8 Million
    EPS -2.73
    Price-to-Earnings (P/E) Ratio -5.02
    Price-to-Sales 0.00
    Price-to-Book 2.86
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 14.53
    Resistance 3 (R3) 14.58 14.37 14.39
    Resistance 2 (R2) 14.37 14.16 14.34 14.34
    Resistance 1 (R1) 14.03 14.03 13.93 13.98 14.30
    Pivot Point 13.82 13.82 13.76 13.79 13.82
    Support 1 (S1) 13.48 13.61 13.38 13.43 13.10
    Support 2 (S2) 13.27 13.48 13.24 13.06
    Support 3 (S3) 12.93 13.27 13.01
    Support 4 (S4) 12.88